Suppr超能文献

在生长激素缺乏的儿童中,吡啶斯的明在白天或夜间均无法增加自发的或生长激素释放激素刺激的生长激素分泌。

Pyridostigmine fails to increase either spontaneous or GHRH-stimulated GH secretion during day or night in growth hormone-insufficient children.

作者信息

Kirk J M, Ross R J, Trainer P J, Froud A L, Davies S C, Savage M O, Besser G M

机构信息

Department of Endocrinology, St Bartholomew's Hospital, London, UK.

出版信息

Clin Endocrinol (Oxf). 1991 May;34(5):407-11. doi: 10.1111/j.1365-2265.1991.tb00313.x.

Abstract

OBJECTIVE The aim of the study was to investigate whether pyridostigmine, a cholinesterase inhibitor which is thought to act at the hypothalamus to inhibit somatostatin secretion, would augment spontaneous or GHRH-stimulated serum GH levels in patients with GH-insufficiency. DESIGN Oral pyridostigmine 60 mg or placebo was administered at the start of a 9-h subcutaneous infusion of either GHRH (1-29)NH2 10 micrograms/kg/h or saline control. Studies were performed during the daytime (0900-1800 h) in five patients, and the night-time (2100-0600 h) in a further five. PATIENTS Ten short, pre-pubertal children (aged 6-11 years; eight boys) with growth hormone insufficiency were studied. MEASURES Blood for serum GH was sampled every 20 min, and analysed using the PULSAR program. RESULTS The subcutaneous infusion of GHRH 10 micrograms/kg/h increased mean serum GH levels (+/- SEM): by day 17.7(+/- 6.8) vs placebo 2.2(+/- 0.4) mU/l (P less than 0.01), and by night 26.9(+/- 3.3) vs 5.5(+/- 1.3) mU/l (P less than 0.05). There was a significant rise in mean 'baseline' GH concentration: by day 5.5(+/- 1.7) vs 1.0(+/- 0.0) mU/l (P less than 0.05); and night 8.2(+/- 2.7) vs 1.3(+/- 0.3) mU/l (P less than 0.05). Pyridostigmine failed to produce a significant overall increase in either spontaneous or GHRH-stimulated GH secretion by day or night, although there was a significant rise in mean GH levels during the 3 h following pyridostigmine administration in the morning: 4.4(+/- 1.1) vs 2.4(+/- 0.5) mU/l (P less than 0.001). GHRH or pyridostigmine given singly or in combination had no significant effect on the number of pulses. Side-effects attributable to pyridostigmine occurred in seven children. CONCLUSIONS Pyridostigmine, either on its own or as an adjuvant therapy in combination with GHRH, acts for only a brief time and does not offer any potential benefit in the management of children with short stature.

摘要

目的

本研究旨在调查吡啶斯的明(一种胆碱酯酶抑制剂,被认为作用于下丘脑以抑制生长抑素分泌)是否会提高生长激素缺乏患者的自发性或生长激素释放激素(GHRH)刺激后的血清生长激素(GH)水平。

设计

在开始9小时皮下输注GHRH(1 - 29)NH2 10微克/千克/小时或生理盐水对照之前,口服60毫克吡啶斯的明或安慰剂。对5名患者在白天(09:00 - 18:00)进行研究,另外5名患者在夜间(21:00 - 06:00)进行研究。

患者

研究了10名青春期前身材矮小的儿童(6 - 11岁;8名男孩),他们患有生长激素缺乏症。

测量

每20分钟采集一次用于检测血清GH的血液样本,并使用PULSAR程序进行分析。

结果

皮下输注10微克/千克/小时的GHRH可提高平均血清GH水平(±标准误):白天为17.7(±6.8)与安慰剂组的2.2(±0.4)毫国际单位/升相比(P < 0.01),夜间为26.9(±3.3)与5.5(±1.3)毫国际单位/升相比(P < 0.05)。平均“基线”GH浓度有显著升高:白天为5.5(±1.7)与1.0(±0.0)毫国际单位/升相比(P < 0.05);夜间为8.2(±2.7)与1.3(±0.3)毫国际单位/升相比(P < 0.05)。吡啶斯的明未能在白天或夜间使自发性或GHRH刺激的GH分泌产生显著的总体增加,尽管在早晨给予吡啶斯的明后的3小时内平均GH水平有显著升高:4.4(±1.1)与2.4(±0.5)毫国际单位/升相比(P < 0.001)。单独或联合给予GHRH或吡啶斯的明对脉冲数无显著影响。7名儿童出现了归因于吡啶斯的明的副作用。

结论

吡啶斯的明单独使用或作为与GHRH联合的辅助治疗,作用时间短暂,在治疗身材矮小儿童方面没有任何潜在益处。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验